A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma

A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma

Symptomatic pituitary adenomas occur with a prevalence of approximately 0.1% in the general population. It is estimated that 5% of pituitary adenomas occur in a familial setting, either in isolated or syndromic form. Recently, loss-of-function mutations in genes encoding succinate dehydrogenase subu...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Michelle Maher, Federico Roncaroli, Nigel Mendoza, Karim Meeran, Natalie Canham, Monika Kosicka-Slawinska, Birgitta Bernhard, David Collier, Juliana Drummond, Kassiani Skordilis, Nicola Tufton, Anastasia Gontsarova, Niamh Martin, Márta Korbonits, Florian Wernig
Natura:	Articolo
Lingua:	English
Pubblicazione:	Bioscientifica 2018-07-01
Serie:	Endocrinology, Diabetes & Metabolism Case Reports
Accesso online:	https://www.edmcasereports.com/articles/endocrinology-diabetes-and-metabolism-case-reports/10.1530/EDM-18-0078

Documenti analoghi

An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma
di: Ali S. Alzahrani, et al.
Pubblicazione: (2023-12-01)

Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
di: Lambert, K, et al.
Pubblicazione: (2017)

Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes
di: Lambert, K, et al.
Pubblicazione: (2017)

Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients
di: Yiqiang Huang, et al.
Pubblicazione: (2018-11-01)

Use of SDHB immunohistochemistry to identify germline mutations of SDH genes
di: Gill AJ
Pubblicazione: (2012-04-01)

Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.
di: Karavitaki, N, et al.
Pubblicazione: (2010)

An analysis of surveillance screening for SDHB-related disease in childhood and adolescence
di: Nicola Tufton, et al.
Pubblicazione: (2019-02-01)

A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy.
di: Soni, A, et al.
Pubblicazione: (2008)

Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction
di: Pankaj Agrawal, et al.
Pubblicazione: (2022-12-01)

The modern management of macroprolactinomas.
di: Grossman, A
Pubblicazione: (1991)

SDHB exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas
di: María Carolina Manotas, et al.
Pubblicazione: (2023-01-01)

Genotype-Phenotype Correlation in Patients With Germline Mutations of VHL, RET, SDHB, and SDHD Genes: Thai Experience
di: Chutintorn Sriphrapradang, et al.
Pubblicazione: (2017-04-01)

Reply to Commentary on "Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction"
di: Pankaj Agrawal, et al.
Pubblicazione: (2023-03-01)

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
di: Wong Nora, et al.
Pubblicazione: (2006-01-01)

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
di: van Nederveen, F, et al.
Pubblicazione: (2009)

Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma
di: DL Goede, et al.
Pubblicazione: (2006-04-01)

The outcome of macroprolactinomas resistant to dopamine agonists
di: Coculescu, M, et al.
Pubblicazione: (2005)

Macroprolactinoma in an adolescent female with primary amenorrhoea
di: Ning Zhang, et al.
Pubblicazione: (2024-12-01)

Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP)
di: Christopher J. Ricketts, et al.
Pubblicazione: (2022-01-01)

Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP).
di: Christopher J Ricketts, et al.
Pubblicazione: (2022-01-01)

Macroprolactinoma resistente aos agonistas dopaminérgicos: relato de caso Macroprolactinoma resistant to dopamine agonists: a case report
di: Rosana Maria dos Reis, et al.
Pubblicazione: (2004-09-01)

SDHB and SDHA Immunohistochemistry in Canine Pheochromocytomas
di: Firas M. Abed, et al.
Pubblicazione: (2020-09-01)

Clinical Characteristics of Macroprolactinomas and Response to Medical Therapy
di: Pooja Tiwari, et al.
Pubblicazione: (2024-06-01)

Successful delivery in the setting of SDHB metastatic paraganglioma
di: M Majumder, et al.
Pubblicazione: (2024-10-01)

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
di: Karavitaki, N, et al.
Pubblicazione: (2013)

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
di: Karavitaki, N, et al.
Pubblicazione: (2013)

Recurrent Macroprolactinoma with Malignant Conversion to Carcinoma with Spinal Metastasis
di: Madeline Mori, et al.
Pubblicazione: (2021-01-01)

Meningitis and CSF Rhinorrhea as Initial Presentations of Untreated Macroprolactinoma
di: Li Yunkai Andrew, et al.
Pubblicazione: (2014-05-01)

Manejo atual dos macroprolactinomas: Revisão da literatura
di: João Antônio Pinheiro Marques, et al.
Pubblicazione: (2008-03-01)

CSF Rhinorrhea: An Early Complication of Dopamine-Sensitive Macroprolactinoma
di: Amitha Padmanabhuni, MD, et al.
Pubblicazione: (2017-01-01)

Effective long-term temozolomide rechallenge in a macroprolactinoma
di: Benedetta Zampetti, et al.
Pubblicazione: (2018-10-01)

Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
di: Srirangalingam, U, et al.
Pubblicazione: (2009)

Bladder paraganglioma, gastrointestinal stromal tumor, and SDHB germline mutation in a patient with Carney-Stratakis syndrome: A case report and literature review
di: Yihang Shi, et al.
Pubblicazione: (2022-10-01)

Clinical and biochemical characteristics of patients presenting with pituitary apoplexy
di: Ali Abbara, et al.
Pubblicazione: (2018-10-01)

Efficacy of Immunohistochemistry for SDHB in the Screening of Hereditary Pheochromocytoma–Paraganglioma
di: Hye-Ryeon Choi, et al.
Pubblicazione: (2021-07-01)

Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
di: Preda, V, et al.
Pubblicazione: (2014)

Cluster Headache Secondary to Macroprolactinoma with Ipsilateral Cavernous Sinus Invasion
di: M. J. Levy, et al.
Pubblicazione: (2012-01-01)

Myxedema Coma Associated with Macroprolactinoma: Case Report and Review of the Literature
di: Elizabeth Jasola Omoniyi, et al.
Pubblicazione: (2022-01-01)

Suppurative meningitis: A life-threatening complication in male macroprolactinomas
di: Farida Chentli, et al.
Pubblicazione: (2013-01-01)

A macroprolactinoma becoming resistant to cabergoline and developing atypical pathology
di: Emilia Sbardella, et al.
Pubblicazione: (2016-10-01)